The famous American vaccine company Profectus settled in Hong Kong First recommend HPV cervical cancer treatment vaccine BALTIMORE, MARYLAND, USA and HONG KONG, April 20, 2018 Profectus Biotech and Medisun Medical Group today announced the opening of a new joint venture in Hong Kong. The primary mission of the new company, ProMed BioSciences, Ltd., is to establish a leading vaccine company focused on the development of preventive and therapeutic vaccines for infectious diseases and cancer. The joint venture will leverage Profectus’ vaccine development expertise, clinically proven vaccine platform technology and a developing vaccine product line, in line with Medisun’s expertise, …